Verrica Pharmaceuticals Inc

Research Verrica Pharmaceuticals Inc (VRCA) on Bullrun: market cap USD 111.66M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVRCA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 111.66M
• Financial periodFY2025
• RevenueUSD 35.58M
• Revenue growth370.2%
• Net income-USD 17.90M
• Free cash flow-USD 17.63M

Valuation Snapshot

latest market cap is USD 111.66M.

About Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts.

Frequently asked questions

What is Verrica Pharmaceuticals Inc's market cap?

Verrica Pharmaceuticals Inc's market capitalization is USD 111.66M.

What does Verrica Pharmaceuticals Inc do?

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.